1. Boieri M, Shah P, Dressel R, Inngjerdingen M. The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview. Front Immunol. 2016;7(333):1–20.
2. Villa NYRM, McFadden G, Cogle CR. Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies. Viruses. 2016;8(3):85.
3. Pasquini MC, Wang Z, Horowitz MM, Gale RP. 2010 report from Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transplant. 2010;2010:87–105.
4. Ghimire S, Weber D, Mavin E, Xn W, Dickinson AM, Holler E. Pathophysiology of GvHD and Other HSCT-Related Major Complications. Front Immunol. 2017;8(79):1–9.
5. Newton-Nash DK. The molecular basis of allorecognition. Assessment of the involvement of peptide. Hum Immunol. 1994;41(2):105–11.